Pembrolizumab/MK-7684 or MK-4830 or MK-5890 or MK-0482
Categoría
Drugs Multinational Subsidiaries
Tipo de registro
Biotech Sanitaria
Nombre socio
Producto / Servicio
Pembrolizumab/MK-7684 or MK-4830 or MK-5890 or MK-0482
Tipo
Biodrugs/ Drugs
Area terapéutica
Oncología
Propiedades/Indicación
KEYMAKER-U01 Master study: A phase 2, Umbrella study with Rolling Arms of Investigational Agents with either Pembrolizumab in combination with Chemotherapy or with Pembrolizumab alone in Patients with Advanced Non-small cell lung cancer (NSCLC)
Fase de desarrollo
P II